Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (ORKA)

Q: What does CUSIP 687604108 represent in this 13F holders report?

CUSIP 687604108 is the security identifier for ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q2 2025?

81 institutional investors reported ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 687604108

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 68,359,580
Total 13F shares: 34,429,035
Share change: +2,650,212
Total reported value: $385,950,468
Price per share: $11.21
Number of holders: 81
Value change: +$30,431,109
Number of buys: 51
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 687604108?
CUSIP 687604108 identifies ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 687604108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Top shareholders of ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	8.1%	5,561,808	$57,064,150	—	31 Mar 2025	13F
Venrock Healthcare Capital Partners III, L.P.	3/4/5	10%+ Owner	— class O/S missing	4,148,428	$47,458,016	—	10 Feb 2025	3/4/5
VR Adviser, LLC	13F	Company	6.1%	4,148,428	$42,562,871	—	31 Mar 2025	13F
Fairmount Funds Management LLC	13F	Company	4.9%	3,371,922	$34,595,920	—	31 Mar 2025	13F
Funicular Funds, LP	3/4/5	Other*, 10%+ Owner	— mixed-class rows	9,179,356 mixed-class rows	$22,903,390	—	15 Dec 2022	3/4/5
RTW INVESTMENTS, LP	13F	Company	2.8%	1,945,649	$19,962,359	—	31 Mar 2025	13F
VANGUARD GROUP INC	13F	Company	2.4%	1,637,433	$16,800,063	—	31 Mar 2025	13F
BRAIDWELL LP	13F	Company	2.3%	1,572,426	$16,133,091	—	31 Mar 2025	13F
Deep Track Capital, LP	13F	Company	2.1%	1,444,709	$14,822,714	—	31 Mar 2025	13F
Commodore Capital LP	13F	Company	2.1%	1,419,714	$14,566,266	—	31 Mar 2025	13F
Polar Capital Holdings Plc	13F	Company	1.5%	1,050,000	$10,773,000	—	31 Mar 2025	13F
Blackstone Inc.	13F	Company	1.1%	783,653	$8,040,280	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	1.1%	747,674	$7,671,135	—	31 Mar 2025	13F
FRANKLIN RESOURCES INC	13F	Company	1.1%	720,547	$7,392,812	—	31 Mar 2025	13F
Funicular Fund, LP	3/4/5	Other*	— mixed-class rows	2,594,952 mixed-class rows	$6,451,130	—	23 May 2022	3/4/5
JANUS HENDERSON GROUP PLC	3/4/5	10%+ Owner	— class O/S missing	2,117,213	$6,302,520	—	16 Aug 2024	3/4/5
Frazier Life Sciences Management, L.P.	13F	Company	0.85%	583,327	$5,984,935	—	31 Mar 2025	13F
Affinity Asset Advisors, LLC	13F	Company	0.8%	545,362	$5,595,414	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.77%	527,791	$5,415,136	—	31 Mar 2025	13F
Cable Car Capital, LP	13F	Company	0.66%	450,000	$4,617,000	—	31 Mar 2025	13F
SR ONE CAPITAL MANAGEMENT, LP	13F	Company	0.63%	430,330	$4,415,186	—	31 Mar 2025	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.6%	411,602	$4,224,000	—	31 Mar 2025	13F
Jefferies Financial Group Inc.	13F	Company	0.59%	405,029	$4,155,598	—	31 Mar 2025	13F
Woodline Partners LP	13F	Company	0.57%	390,804	$4,009,649	—	31 Mar 2025	13F
Redmile Group, LLC	13F	Company	0.57%	386,963	$3,970,240	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.52%	352,585	$3,619,224	—	31 Mar 2025	13F
Avidity Partners Management LP	13F	Company	0.52%	352,124	$3,612,792	—	31 Mar 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.51%	350,036	$3,591,369	—	31 Mar 2025	13F
Point72 Asset Management, L.P.	13F	Company	0.5%	342,399	$3,513,014	—	31 Mar 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.36%	244,199	$2,505,482	—	31 Mar 2025	13F
Ikarian Capital, LLC	13F	Company	0.26%	175,000	$1,795,499	—	31 Mar 2025	13F
ADAR1 Capital Management, LLC	13F	Company	0.19%	132,780	$1,362,323	—	31 Mar 2025	13F
S.c.a. Candriam	13F	Individual	0.17%	116,698	$1,197,321	—	31 Mar 2025	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.13%	87,501	$897,761	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	0.13%	86,681	$889,347	—	31 Mar 2025	13F
BARCLAYS PLC	13F	Company	0.11%	75,333	$772,917	—	31 Mar 2025	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.1%	65,749	$674,585	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.09%	59,585	$611,342	—	31 Mar 2025	13F
TORONTO DOMINION BANK	13F	Company	0.09%	58,332	$598,486	—	31 Mar 2025	13F
B Group, Inc.	13F	Company	0.09%	58,215	$597,286	—	31 Mar 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.08%	54,126	$555,333	—	31 Mar 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.08%	53,615	$550,090	—	31 Mar 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.08%	52,026	$533,787	—	31 Mar 2025	13F
HRT FINANCIAL LP	13F	Company	0.07%	46,511	$477,000	—	31 Mar 2025	13F
TD ASSET MANAGEMENT INC	13F	Company	0.07%	45,876	$470,688	—	31 Mar 2025	13F
OMERS ADMINISTRATION Corp	13F	Company	0.07%	44,900	$460,674	—	31 Mar 2025	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.06%	42,919	$440,349	—	31 Mar 2025	13F
Weiss Asset Management LP	13F	Company	0.06%	40,000	$410,400	—	31 Mar 2025	13F
ExodusPoint Capital Management, LP	13F	Company	0.05%	35,912	$368,000	—	31 Mar 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.05%	35,800	$367,308	—	31 Mar 2025	13F

Institutional Holders of Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (ORKA) as of Q2 2025

As of 30 Jun 2025, Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (ORKA) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,429,035 shares. The largest 10 holders included FMR LLC, VR ADVISER, LLC, Fairmount Funds Management LLC, BlackRock, Inc., RTW INVESTMENTS, LP, Deep Track Capital, LP, VANGUARD GROUP INC, BRAIDWELL LP, Commodore Capital LP, and FRANKLIN RESOURCES INC. This page lists 81 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.